# The Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer. Diagnosis of Pancreatic Cancer

> **NCT06497777** · — · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Pancreas Adenocarcinoma
- MicroRNA

## Interventions

- **GENETIC:** MicroRNA (mir-642b-3p)

## Key facts

- **NCT ID:** NCT06497777
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-06
- **Primary completion:** 2025-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06497777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06497777, "The Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer. Diagnosis of Pancreatic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06497777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*